Beyond signaling disruptions, DS-ALL is also characterized by recurrent epigenetic abnormalities, particularly affecting the E1A-binding protein p300 (EP300) and CREBBP genes, which regulate histone acetylation and transcription [43]. Here, EP300 is linked to acute lymphoblastic leukemia.